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ABSTRACT
Background: Mucus is pre-epithelial gastric layer that may prevent damages due to direct contact between 
aspirin and gastric epithelial cells. The integrity of gastric mucosa and mucous cellular reaction may serve as 
primary and secondary prevention of extended aspirin-induced gastric mucosal damage. The aim of this study 
was to prove the function of mucus as defensive factor in rats.
Method: The study was conducted in twenty white rats of the Sprague-Dawley strain at Department of 
Pathology and Clinical Reproduction, Bogor Agricultural University, between January and December 2008. The 
rat in the treatment group were given 400 mg aspirin diluted in aqua bidest through intra-gatric canules; while 
the control group received aqua bidest only once daily for 3 days. Necropsies, macroscopic and microscopic 
observation were performed by counting the number of Alcian blue-periodic acid Schiff-stained mucous cells 
at fundus/corpus and antrum/pylorus regions. Data analysis was performed using ANOVA and Duncan test. 
Results: The number of mucous cells with positive lesions in the treatment group was significantly different 
from the control group at both regions. There was no significant difference of negative lesions between treatment 
and control group at both regions. At antrum/pylorus region, there was no difference of negative lesions between 
treatment and control groups; however, both groups demonstrated significant difference of positive lesions in 
treatment group. 
Conclusion: In primary prevention for gastric mucosal lesions, there is no increasing number of mucous 
cells in normal mucosa. Increasing number of mucous cells is a secondary prevention against extended aspirin-
induced gastric mucosal damage. 
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ABSTRAK
Latar belakang: Mukus merupakan lapisan pre epitel untuk mencegah efek langsung asam asetil salisilat/
aspirin terhadap epitel gaster. Keutuhan mukosa merupakan pencegahan primer dan reaksi sel mukus sebagai 
pencegahan sekunder terhadap perluasan lesi mukosa akibat aspirin. Tujuan penelitian ini yaitu membuktikan 
fungsi mukus dalam pencegahan primer maupun sekunder sebagai faktor defensif pada tikus.
Metode: Penelitian ini dilakukan pada hewan coba tikus putih jenis Sprague-Dawley sebanyak 20 ekor di 
Bagian Patologi dan Klinik Reproduksi, Fakultas Kedokteran Hewan, Institut Pertanian Bogor pada bulan Januari 
hingga Desember 2008. Pada tikus yang mendapat perlakuan diberikan aspirin dosis 400 mg yang dilarutkan pada 
akuabides melalui kanul langsung ke dalam lambung, sedangkan pada kelompok kontrol hanya diberikan akuabides 
saja sekali sehari selama 3 hari. Nekropsi, pengamatan makroskopik dan mikroskopik lambung dilakukan dengan 
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menghitung jumlah sel mukus pada regio fundus/korpus dan regio antrum/pilorus dengan pewarnaan periodik 
acid-Schiff (PAS) Alcian biru. Analisis statistik dilakukan dengan uji ANOVA dan Duncan.
Hasil: Jumlah sel mukus pada kelompok perlakuan dengan lesi positif terdapat perbedaan bermakna antara 
kelompok kontrol pada regio fundus/korpus dan regio antrum/pilorus. Tidak terdapat perbedaan bermakna pada 
kelompok dengan lesi negatif baik pada kelompok yang mendapat perlakuan atau kontrol pada kedua regio. Pada 
regio antrum/pilorus tidak terdapat perbedaan bermakna pada kelompok perlakuan dengan lesi negatif dengan 
kelompok kontrol, namun kedua kelompok tersebut berbeda bermakna dengan kelompok perlakuan dengan lesi 
positif.
Kesimpulan: Pada pencegahan primer lesi mukosa gaster tidak terdapat peningkatan jumlah sel mukus 
pada mukosa normal. Peningkatan jumlah sel mukus merupakan pencegahan sekunder terhadap perluasan 
lesi mukosa gaster akibat aspirin. 
Kata kunci: OAINS/ASA, sel mukus, lesi mukosa gaster, tikus
INTRODUCTION
Severe gastric mucosal damage due to non-steroid 
anti inflammatory drugs/aspirin (NSAIDs/ASA) is 
caused by the imbalance between the aggressive factors 
and the defensive factors. Direct contact between 
NSAIDs and epithelial cells of gastric mucosa is the 
initial process of primary mechanism underlying 
NSAID-associated gastric mucosal damage. The 
gastric mucosal defense consists of pre-epithelial, 
epithelial and sub-epithelial barriers.1,2 Pre-epithelial 
defense including the mucus layer is the fore barrier 
that may determine the occurrence of acute gastric 
mucosal damage. Lesions in gastric mucosa are mostly 
due to failure of epithelial mucus to protect against 
injury; therefore, direct contact with epithelial layer 
will likely to be occurred. Subsequently, inflammatory 
reactions which are generally initiated and amplified 
by inflammatory mediators may occur and can result 
in further damage of epithelial layer.3,4 The condition 
would be exaggerated by gastric acid that may facilitate 
NSAID/ASA penetration into gastric epithelial cells, 
where they trapped within the cells causing local injury. 
It will cause a wide range of damage on epithelial layer 
starting from erosion to ulcer, either with or without 
bleeding. This kind of local reactions are more likely 
to occur in some parts of gastric mucosa, especially 
where the mucus layer is thin or non-existent.1,5-8
NSAIDs/ASA may not cause gastric mucosal 
damage in all cases. Therefore, it has been proposed 
that mucus layer as the primary fore barrier of gastric 
mucosa may have important role. The aim of this study 
was to provide evidences that mucus layer can prevent 
NSAIDs/ASA-induced gastric mucosal damage in rats. 
We hypothesized that mucus layers, particularly the 
number of mucous cells could prevent the occurrence 
of NSAIDs/ASA-induced lesions in gastric mucosa.
METHOD
The study used twenty male white rats (Rattus 
norvegicus)  of  the Sprague-Dawley strain 
as experimental animals to serve as model for 
human condition since their anatomical structure 
of gastrointestinal system is similar with human. 
Furthermore, it may provide evidences of affecting 
factors after the necropsy had been performed. The 
rats were 2 months old and the average weight of 
each rat was ± 250 g. Those experimental animals 
were taken from Non Ruminansia division and 
Satwa Harapan (NRSH), Faculty of Animal Science, 
Bogor Agricultural University in Bogor. The study 
was conducted at Department of Pathology and 
Clinical Reproduction, Faculty of Veterinary Science, 
Bogor Agricultural University between January and 
December 2008. The animals were categorized into 
two groups, i.e. the treatment and control groups. Each 
group consisted of 10 rats. Each rat in the treatment 
group was given 400 mg of acetyl salicylic acid 
(ASA)/aspirin as the non-steroid anti-inflammatory 
drug, which was consistent with the references of our 
literatures. We used ASA in its pure form of a white 
crystalline solid. 
Prior to the usage of rats in this study, the rats were 
fed with irradiated sterile pellet at dose of 10 Kgray. 
Each of rat was fed as much 25 g of pellets every 
day. Adaptation for the rat was performed during 
three weeks period by administering 250 mg/kgBW 
of tetracyclin antibiotic for three days and 10 mg/
kgBW of antihelmintic, Albendazole 5%, every week 
for 3 weeks. Moreover, anti-Cryptococcus drug, i.e. 
fluconazole was administered at dose of 50 mg/kgBW 
once daily for three days. Pre-eliminary study has 
been performed to eliminate bias which may affect the 
condition of gastric mucosa. 
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The rats are being weighed every day. ASA 
was administered to three-hour fasting rats in the 
treatment group using intra-gastric tube at dose of 
400 mg ASA diluted in 2 mL aqua, once daily during 
three days. Similar procedures were conducted in 
the control group, but the rats in the control group 
received solution containing aqua only. Afterwards, 
necropsies were performed in both groups under ether 
anesthesia. Necropsy was conducted along the linea 
alba through opening of skin and fascia. The stomach 
was separated from its surrounding and taken out. 
Subsequently, macroscopic observation of gastric 
mucosa was done after incision along the greater 
curvature. After macroscopic observation had been 
completed, the stomach was preserved in 10% buffered 
neutral formalin (10% BNF) and stored for further 
process. Microscopic observation was performed at 
two gastric regions, i.e. the fundus/corpus and antrum/
pylorus. Histopathological examination was done with 
hematoxyllin eosin (HE) and periodic acid Schiff 
(PAS) Alcian Blue staining at each gastric region. The 
number of mucous cells was counted in 10 high power 
field for each layer of gastric regions. 
Quantitative data including the mean value of the 
amount of mucus cells in each high power field was 
analyzed by one-way ANOVA test using SPSS version 
13.0. One-way ANOVA test was used to compare 
control group (C), treatment group with negative 
lesion (TNL) and treatment group with positive lesion 
(TPL). Significant results were further analyzed using 
the Duncan test, p < 0.05 was considered statistically 
significant. 
RESULTS
Statistical analysis on the number of mucous cells 
in the fundus/corpus region demonstrated that there 
was a significant difference between treatment groups 
with positive lesions (TPL) and the control group; 
however, no significant difference was found between 
the treatment group with negative lesions (TNL) and 
the control group (Table 1). 
Furthermore, statistical analysis in the antrum/
pylorus region indicated that there were significant 
differences between TPL group and TNL group, and 
the control group. However, no significant difference 
was found between TNL group and the control group 
(Table 2). 
Histopathological findings of gastric mucosa 
indicated an increasing number of mucous cells in 
the treatment group compared to the control group 
(Figure 1). 
Table 1. The number of mucous cells in fundus/corpus region
Group Amount of mucous cells
Control 10.43  +   4.28a
Treatment group with negative lesion 16.50  +   0.71ab
Treatment group with positive lesion 18.25  +  5.06b
Different alphabet shows p < 0.05
Table 2. The number of mucous cells in anthrum/pylorus region
Group Amount of mucous cells
Control 11.67  +   1.97a
Treatment group with negative lesion 11.00  +   2.74a
Treatment group with positive lesion  16.50  +   4.43b
Different alphabet shows p < 0.05
DISCUSSION
Mucus as one of defensive factors has important 
role in protecting gastric mucosa. The protective 
function of mucus is determined by the activity of 
mucous cells activity.3,4,5 This study attempted to 
provide evidences on the role of mucus in preventing 
gastric mucosal damage. Such study has never been 
conducted by other investigators. Increased activity of 
mucous cells was found when mucosal lesion occurred. 
It may become a secondary prevention strategy of 
our body to inhibit further expansion of the lesion. 
Moreover, when mucosal lesion was not found in the 
TNL group, the activity of mucous cells was similar 
to the control group. Direct contact between NSAIDs 
and gastric epithelial layer would bring great effect 
resulting in mucosal reaction that may increase the 
number of mucous cells. In the TPL group at fundus/
corpus region, this study revealed that there was no 
significant difference on the number of mucous cells 
between TPL and control group. Such finding indicates 
that the important role of mucus in TPL group could not 
be observed due to shorter period of contact between 
the drugs and mucosa. Similar condition was found 
in TNL group. 
Figure 1. Histopathological findings of gastric mucosa demon-
strating mucous cells in the control group (A) and treatment 
group (B), which shows gastric epithelial layer with higher 
number of mucous cells in the treatment group
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The increased number of mucous cells induced by 
ASA stimulation may exert similar effect even though 
the mucosal lesion does not occur. Mucosal lesion may 
be affected by the length of contact period between 
ASA and gastric mucosa, the quality of mucus and 
bicarbonate secretion.4,6,7,9,10 
We found that after being induced with aspirin, the 
number of mucous cells in the antrum/pylorus region 
was different from those in corpus/fundus region. There 
were significant differences in TPN group between 
the control and TNL group. In contrast, there was no 
significant difference between the control group and 
TNL group. 
Such findings indicate that the number of mucous 
cells in both control and TNL groups was not affected 
by direct contact between aspirin and gastric epithelial 
layer. Furthermore, in TPL group, it may serve as 
secondary strategy to prevent expansion of lesions. 
Thus, mucus has important function as the fore barrier 
to prevent devastating effects of aspirin/ASA on gastric 
mucosa, particularly in the epithelial and sub-epithelial 
layer.6,7,9,10 Therefore, it can be used as a strategy 
to prevent the occurrence of aspirin/ASA-induced 
mucosal lesion. 
CONCLUSION
Gastric mucosal defense mechanism is highly 
determined by pre-epithelial component, especially 
mucus thickness related to mucus cells production. 
The production of mucus will increase when gastric 
mucosal lesion has occurred. However, when there is 
no mucosa lesion, the activity of mucous cells is similar 
to the control group. It indicates that mucus has an 
important role as fore barrier to prevent the damaging 
effects of aspirin on gastric epithelial through primary 
or secondary prevention, which could be measured as 
the number of mucous cells. 
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